Resorcinol

DERMATOLOGICALS

Key facts

Resorcinol is a drug catalogued in DrugCentral. DrugCentral lists 9 molecular targets, including ca, CA5B and CA12. Recorded indications include Acne vulgaris, Acneiform eruption, Itching of skin and Minor Skin Wound Pain.

• Molecular targets: ca, CA5B, CA12 and CA2 (9 listed in DrugCentral).
• Indications: Acne vulgaris, Acneiform eruption, Itching of skin, Minor Skin Wound Pain and Skin irritation.
• ATC code: D10AX02 (Other anti-acne preparations for topical use).
• Molecular formula: C6H6O2; molecular weight 110.11 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

• Acne vulgaris
• Acneiform eruption
• Itching of skin
• Minor Skin Wound Pain
• Skin irritation

Contraindications (18)

• Anemia due to enzyme deficiency
• Blister
• Conduction disorder of the heart
• Condyloma acuminatum
• Decreased respiratory function
• Deficiency of cytochrome-b>5< reductase
• Deficiency of glucose-6-phosphate dehydrogenase
• Denuded skin
• Diabetes mellitus
• Eruption of skin
• Folliculitis
• Infection of skin AND/OR subcutaneous tissue
• Inflammatory dermatosis
• Kidney disease
• Methemoglobinemia
• Open wound
• Peripheral vascular disease
• Seizure disorder

Mechanism & targets

Molecular targets (9)

Target	Gene	Action	Activity
Carbonic anhydrase	ca	unknown	Ki 5.19
Carbonic anhydrase 5B, mitochondrial	CA5B	unknown	Ki 5.15
Carbonic anhydrase 12	CA12	unknown	Ki 5.12
Carbonic anhydrase 2	CA2	unknown	Ki 5.11
Carbonic anhydrase 5A, mitochondrial	CA5A	unknown	Ki 5.06
Carbonic anhydrase 14	CA14	unknown	Ki 4.97
Carbonic anhydrase 13	Ca13	unknown	Ki 4.20
Carbonic anhydrase 9	CA9	unknown	Ki 4.16
Prostaglandin G/H synthase 1	PTGS1	unknown	Kd 4.06

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
D10AX02	DERMATOLOGICALS › ANTI-ACNE PREPARATIONS › ANTI-ACNE PREPARATIONS FOR TOPICAL USE › Other anti-acne preparations for topical use
S01AX06	SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Other antiinfectives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Resorcinol is on its molecule page.

• Molecular formula: C₆H₆O₂
• Molecular weight: 110.11 g/mol
• CAS number: 108-46-3
• InChIKey: GHMLBKRAJCXXBS-UHFFFAOYSA-N
• PubChem CID: 5054

OC1=CC(O)=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Resorcinol used for?

DrugCentral lists the following indications for Resorcinol: Acne vulgaris, Acneiform eruption, Itching of skin, Minor Skin Wound Pain and Skin irritation.

How does Resorcinol work?

Its molecular targets in DrugCentral include ca, CA5B, CA12 and CA2.

What is the chemical formula of Resorcinol?

Resorcinol has the molecular formula C6H6O2 and a molecular weight of 110.11 g/mol.

Sources

• DrugCentral drug card 3524 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL24147 — compound record and bioactivity
• PubChem CID 5054 — chemical identifiers
• DrugBank DB11085 — drug record
• FDA UNII YUL4LO94HK — substance identity
• DailyMed: FDA labels for Resorcinol — current prescribing information (label search)
• UniProt Q9Y2D0 (CA5B) — target protein
• UniProt O43570 (CA12) — target protein
• UniProt P00918 (CA2) — target protein
• UniProt P35218 (CA5A) — target protein
• UniProt Q9ULX7 (CA14) — target protein
• UniProt Q16790 (CA9) — target protein

How this page is built: methodology · editorial policy & corrections.